别名:EC 6.2.1.7; FACVL3; FATP5; MGC143799; S27A5应用:WB,IHC,ICC
反应种属:Human
规格:50μl/100μl
Description |
---|
Acyl-CoA synthetase involved in bile acid metabolism. Proposed to catalyze the first step in the conjugation of C24 bile acids (choloneates) to glycine and taurine before excretion into bile canaliculi by activating them to their CoA thioesters. Seems to activate secondary bile acids entering the liver from the enterohepatic circulation. In vitro, also activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol.Steinberg S.J., Mol. Genet. Metab. 68:32-42(1999).Steinberg S.J., J. Biol. Chem. 275:15605-15608(2000).Mihalik S.J., J. Biol. Chem. 277:24771-24779(2002). |
Specification | |
---|---|
Aliases | EC 6.2.1.7; FACVL3; FATP5; MGC143799; S27A5 |
Entrez GeneID | 10998; |
Swissprot | Q9Y2P5 |
WB Predicted band size | 75kDa |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | Synthesized peptide derived from internal of human SLC27A5. |
Formulation | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Application | |
---|---|
WB | 1/500-1/3000 |
IHC | 1/50-1/100 |
ICC | 1/100-1/500 |
![]() |
Western blot analysis of extracts from HepG2 cells, using SLC27A5 antibody P42319. |
![]() |
Immunofluorescence analysis of A549 cells, using SLC27A5 antibody P42319. |
![]() |
Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue using SLC27A5 antibody P42319. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
发表回复